Fig. 3: SS-OCTA 6 × 6 mm scans of the case of growing MNV lesion for 33-month follow-up and the case of stable MNV for 24-month follow-up. | Eye

Fig. 3: SS-OCTA 6 × 6 mm scans of the case of growing MNV lesion for 33-month follow-up and the case of stable MNV for 24-month follow-up.

From: Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity

Fig. 3

A–F 33-month Follow-up of growing MNV lesion. A SS-OCTA photographs show a treatment-naïve nonexudative MNV lesion in the patient’s right eye at baseline. B SS-OCTA shows that the area of the MNV lesion increased to 0.522 mm2 in the third month and C enlarged to 1.532 mm2, with exudation, in the thirteenth month. D SS-OCTA photographs of the MNV lesion detected after anti-VEGF therapy and E the symptomatic recurrence of exudation in the 29th month. F SS-OCTA shows that the area of the MNV lesion increases to 1.326 mm2. G–J 24-month follow-up of stable MNV lesion. G SS-OCTA photographs show a 2.760 mm2 subclinical MNV lesion in the patient’s right eye at baseline. H SS-OCTA shows that the area of the subclinical MNV lesion increased to 2.921 mm2 in the sixth month and I enlarged to 3.282 mm2 in lesion area in the ninth month. J SS-OCTA photograph shows the lesion area increased into 3.905 mm2 at the last visit (the 24th month).

Back to article page